Page last updated: 2024-11-05

tranexamic acid and Brain Vascular Disorders

tranexamic acid has been researched along with Brain Vascular Disorders in 4 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Qiu, J1
Sun, X1
Zhang, W1
Ke, X1
Yang, G1
Zhang, L1
Benhamou, D1
Keita, H1
Ducloy-Bouthors, AS1
Mangano, DT1
Tudor, IC1
Dietzel, C1
Neu, I1
Schrader, A1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy of Postoperative Pain Control Between Transarticular VS Periartiucular Multimodal Drug Infiltration in Total Hip Arthroplasty: Double-blinded Randomized Control Trial[NCT05325671]120 participants (Anticipated)Interventional2022-04-05Not yet recruiting
The Effect of Tranexamic Acid (TXA) on Blood Loss and Transfusion Rates in Burn Wound Surgery - A Randomized, Double-Blinded Placebo-Controlled Trial[NCT02753816]25 participants (Actual)Interventional2016-04-30Terminated (stopped due to Study enrollment and goals unable to be reached.)
Influence of Elevated Baseline Serum Creatinine and Body Composition on Acute Kidney Injury in Cardiac Surgery - The InCreAS Trial[NCT02598271]200 participants (Actual)Observational2016-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Blood Transfusion Rates, Defined Nominally (Binary) as Having at Least One Transfusion

To determine the impact of perioperative administration of Tranexamic Acid on transfusion rates in major burn surgeries. (NCT02753816)
Timeframe: First burn surgery to hospital discharge

InterventionPatients with 1 or more transfusions (Number)
Tranexamic Acid2
Placebo3

Effect of Tranexamic Acid on the Total Length of Hospital Admission for a Large (350 cm2) Burn Injury

To determine the impact of Tranexamic Acid on total hospital length of stay by comparing the hospital admission date and the hospital discharge date. This determination will take into account current burn size and location, procedures performed and their effect on wound healing and skin graft survival. (NCT02753816)
Timeframe: Hospital admission to hospital discharge

InterventionDays (Median)
Tranexamic Acid23
Placebo9

Intraoperative Blood Loss in mL

To determine the impact of perioperative administration of Tranexamic Acid on blood loss in major burn surgeries. (NCT02753816)
Timeframe: Intraoperative, average 122 minutes

InterventionmL (Median)
Tranexamic Acid100
Placebo325

Reviews

1 review available for tranexamic acid and Brain Vascular Disorders

ArticleYear
Coagulation changes and thromboembolic risk in COVID-19 obstetric patients.
    Anaesthesia, critical care & pain medicine, 2020, Volume: 39, Issue:3

    Topics: Anticoagulants; Autoantibodies; Betacoronavirus; Blood Proteins; Cerebrovascular Disorders; Contrain

2020

Trials

1 trial available for tranexamic acid and Brain Vascular Disorders

ArticleYear
Effect of topical tranexamic acid in total hip arthroplasty patients who receive continuous aspirin for prevention of cardiovascular or cerebrovascular events: A prospective randomized study.
    Orthopaedics & traumatology, surgery & research : OTSR, 2019, Volume: 105, Issue:7

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement

2019

Other Studies

2 other studies available for tranexamic acid and Brain Vascular Disorders

ArticleYear
The risk associated with aprotinin in cardiac surgery.
    The New England journal of medicine, 2006, Jan-26, Volume: 354, Issue:4

    Topics: Adult; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Pr

2006
The risk associated with aprotinin in cardiac surgery.
    The New England journal of medicine, 2006, Jan-26, Volume: 354, Issue:4

    Topics: Adult; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Pr

2006
The risk associated with aprotinin in cardiac surgery.
    The New England journal of medicine, 2006, Jan-26, Volume: 354, Issue:4

    Topics: Adult; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Pr

2006
The risk associated with aprotinin in cardiac surgery.
    The New England journal of medicine, 2006, Jan-26, Volume: 354, Issue:4

    Topics: Adult; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Cardiac Surgical Pr

2006
[The intensive treatment of apoplexy (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1980, Mar-14, Volume: 122, Issue:11

    Topics: Arrhythmias, Cardiac; Blood Viscosity; Brain Edema; Cerebrovascular Disorders; Dexamethasone; Dextra

1980